CARBERRY CHRISTINE A. (Chief Operating Officer) sold 9.4% of their position (10.47K shares) of KERYX BIOPHARMACEUTICALS INC on the open market
Open‑market sale worth $33.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/13/2018ACC: 0000899243-18-030876
Officer· Chief Operating Officer
Since Jul 2018
-533.62K
Net shares
Net seller
$33.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
533.62K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−10.47K
Price / share
$3.22
Trade value
$33.71K
% of position
9.4%
12/11/2018
111.11K→100.65K
Common Stock
Direct
Shares
−100.65K
Price / share
—
Trade value
—
% of position
New position
12/12/2018
100.65K→0.00
Total
Net shares
−111.11K
Net value
-$33.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2018 | S · Sale | −10.47K | $3.22 | $33.71K | 9.4% | 111.11K | 100.65K |
| Common Stock Direct | 12/12/2018 | D · Disposition | −100.65K | — | — | New position | 100.65K | 0.00 |
| Total | −111.11K | -$33.71K | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common Stock
422.50K shares
Shares
−422.50K
Strike price
Held after
0.00
Exercisable
—
12/12/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock422.50K shares | 12/12/2018 | D · Disposition | −422.50K | — | 0.00 |